Endexx Corporation (OTC: EDXC)
Pitch Promotion • 2m 5s
Endexx Corporation (OTC: EDXC), along with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites® is its CBD-infused soft chews for dogs and cats. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The company also has two technology products and services that launched in 2014: m3hub and AutoSpense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical-grade marijuana that maintains compliance with federal, state, and local regulations. It is intended to provide a smooth transition to eventual federal mandates. AutoSpense™ is a commercial-grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, AutoSpense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites include www.cbdunlimited.com, www.endexx.com, and www.phytobites.com.
Up Next in Pitch Promotion
-
SDT Holdings: Significant Upside Pote...
SDT Holdings, Inc. (OTC: WUHN) is a Montreal-based industrial technology holding company that focuses on the development, production and commercialization of its 4 subsidiaries: Mining Electrification, Cryptocurrencies/blockchain, Industrial Batteries, Internet of Things and Artificial Intelligen...
-
Eco-Stim Energy Solutions (NASDAQ: ESES
Eco-Stim Energy Solutions (NASDAQ: ESES) is an environmentally focused oilfield service and technology company providing proprietary field management technologies, well stimulation, and completion services to oil and gas producers drilling in the rapidly expanding international unconventional sha...
-
TapImmune Inc. (NASDAQ: TPIV)
TapImmune Inc. (NASDAQ: TPIV) is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company’s next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a ...
